Survival from prostate cancer in england and wales up to 2001

British Journal of Cancer

Volumn 99, Issue , 2008, Pages S75-S77

  Rowan, S ^a   Rachet, B ^b   Alexe, D M ^b   Cooper, N ^a   Coleman, M P ^b  

^a OFFICE FOR NATIONAL STATISTICS   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PROSTATE SPECIFIC ANTIGEN;

CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CRYOTHERAPY; ECHOGRAPHY; FAMILY HISTORY; HORMONAL THERAPY; HUMAN; LOW LEVEL LASER THERAPY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RISK FACTOR; SHORT SURVEY; UNITED KINGDOM;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ENGLAND; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS; WALES;

EID: 52449089884     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604595     Document Type: Article

References (19)

1. Berrino F, Estève J, Coleman MP (1995) Basic issues in the estimation and comparison of cancer patient survival. In Survival of Cancer Patients in Europe: the EUROCARE Study (IARC Scientific Publications No. 132), Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estève J (eds), pp 1–14. International Agency for Research on Cancer: Lyon
2. Brenner H, Rachet B (2004) Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer 40: 2494–2501
3. Breslow N, Chan CW, Dhom G, Drury RA, Franks LM, Gellei B, Lee YS, Lundberg S, Sparke B, Sternby NH, Tulinius H (1977) Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyon, France. Int J Cancer 20: 680–688
4. Coleman MP, Babb P, Damiecki P, Grosclaude PC, Honjo S, Jones J, Knerer G, Pitard A, Quinn MJ, Sloggett A, De Stavola BL (1999) Cancer Survival Trends in england and wales 1971–1995: Deprivation and NHS Region. Studies on Medical and Population Subjects No. 61. The Stationery Office: London
5. Coleman MP, Gatta G, Verdecchia A, Estève J, Sant M, Storm HH, Allemani C, Ciccolallo L, Santaquilani M, Berrino F, EUROCARE Working Group (2003) EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 14(5): 128–149
6. de Koning HJ, Auvinen A, Berenguer Sanchez A, Calais da Silva F, Ciatto S, Denis L, Gohagan JK, Hakama M, Hugosson J, Kranse R, Nelen V, Prorok PC, Schröder FH (2002) Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer 97: 237–244
7. Evans HS, Møller H (2003) Recent trends in prostate cancer incidence and mortality in southeast England. Eur Urol 43: 337–341
8. Hakama M, Coleman MP, Alexe DM, Auvinen A (2008) Cancer screening. In Responding to the Challenge of Cancer in Europe, Coleman MP, Alexe DM, Albreht T, McKee CM (eds), pp 69–92. Institute of Public Health of the Republic of Slovenia: Ljubljana
9. Horwich A, Waxman J, Schroder FH (1995) Tumours of the prostate. In Oxford Textbook of Oncology, Peckham M, Pinedo HM, Veronesi U (eds) 2 edn, pp 1498–1530. Oxford Medical Publications: New York
10. Kirby RS (1996a) Recent advances in the medical management of prostate cancer. Br J Clin Pract 50: 88–93
11. Kirby RS (1996b) The future management of prostate cancer? Eur Urol 29(Suppl 2): 132–133
12. Office for National Statistics (2003) Mortality Statistics: Cause, england and wales, 2002. Series DH2 No. 29. Office for National Statistics: London
13. Pashayan N, Powles JW, Brown C, Duffy SW (2006a) Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia. Br J Cancer 95(3): 401–405
14. Pashayan N, Powles JW, Brown C, Duffy SW (2006b) Incidence trends of prostate cancer in East Anglia, before and during the era of PSA testing. Br J Cancer 95(3): 398–400
15. Platz EA, Giovannucci E (2006) Prostate cancer. In Cancer Epidemiology and Prevention. Schottenfeld D, Fraumeni JF (eds) 3 edn, pp 1128–1150. Oxford University Press: Oxford
16. Quinn MJ, Babb P, Brock A, Kirby L, Jones J (2001) Cancer Trends in england and wales 1950–1999. Studies on Medical and Population Subjects No. 66. Office for National Statistics: London
17. Rachet B, Woods LM, Mitry E, Riga M, Cooper N, Quinn MJ, Steward J, Brenner H, Estève J, Sullivan R, Coleman MP (2008) Cancer survival in england and wales at the end of the 20th century. Br J Cancer 99(Suppl 1): S2–S10
18. Ross RK, Schottenfeld D (1996) Prostate cancer. In Cancer Epidemiology and Prevention. Schottenfeld D, Fraumeni JF (eds) 2 edn, pp 1180–1206. Oxford University Press: Oxford
19. Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli P-M, Faivre J, Grosclaude PC, Hédelin G, Matsuda T, Møller H, Moller T, Verdecchia A, Capocaccia R, Gatta G, Micheli A, Santaquilani M, Roazzi P, Lisi D, EUROCARE Working Group (2003) EUROCARE-3: survival of cancer patients diagnosed 1990–94–results and commentary. Ann Oncol 14(5): 61–118